🇺🇸 FDA
Patent

US 11896682

Radiolabeled MET binding proteins for immuno-PET imaging and methods of use thereof

granted A61KA61K51/103A61K51/1093

Quick answer

US patent 11896682 (Radiolabeled MET binding proteins for immuno-PET imaging and methods of use thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Feb 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
47
CPC classes
A61K, A61K51/103, A61K51/1093, A61P, A61P35/00